Enhancing Resilience in Senior Community Residents

Not Applicable

Completed

• Conditions: Quality of Life; Stress, Psychological
• Interventions: Behavioral: SMART-3RP Group Intervention

• Registration Number: NCT05438134
• Lead Sponsor: Massachusetts General Hospital

Brief Summary

This randomized waitlist-controlled trial tests the efficacy of the Stress Management and Resiliency Training Relaxation Response Resiliency Program (SMART-3RP), a mind-body intervention, to enhance resilience and flourishing among residents in continuing care retirement communities. The investigators hypothesize that participants in the SMART-3RP group will report greater increases in resilience and flourishing relative to participants in the control group.

Detailed Description

This randomized control trial tests the efficacy of the Stress Management and Resiliency Training Relaxation Response Resiliency Program (SMART-3RP) to improve resilience and flourishing among older adults residing in continuing care retirement communities relative to a wait-list control group. At enrollment, participants will be randomly assigned to the intervention group or the control group using computer generated 1:1 blocked randomization stratified by community site. The intervention group will receive the SMART-3RP program immediately upon enrollment; the wait-list control group will be invited to receive the SMART-3RP program after the final survey time point. An estimate of 360 participants will be recruited from up to nine geographically diverse Erickson Senior Living communities.

Study Timeline

• Study Start: 2022-06-24
• Study First Submitted: 2022-06-24
• Study First Submitted QC: 2022-06-24
• Study First Posted: 2022-06-29
• Primary Completion: 2023-04-05
• Study Completion: 2023-04-05
• Status Verified: 2023-11
• Last Update Submitted: 2023-11-03
• Last Update Posted: 2023-11-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 288

Inclusion Criteria

• Resident of an Erickson Senior Living community
• Currently residing in an Erickson Senior Living apartment home
• Sufficient English language skills to participate in study procedures

Exclusion Criteria

• Unable or unwilling to provide informed consent
• Unable or unwilling to participate in in-person group sessions

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
SMART-3RP Group Intervention	SMART-3RP Group Intervention	Residents will participate in 9 structured weekly group sessions which incorporates stress management and relaxation training upon enrollment.
Waitlist Control Group Intervention	SMART-3RP Group Intervention	Residents will participate in 9 structured weekly group sessions which incorporates stress management and relaxation training after the final survey time point.

Primary Outcome Measures

Name	Time	Method
Flourishing: Flourishing Measure (FM)	Up to 12 weeks	We will investigate longitudinal differences in flourishing between study groups (FM score range 0-10), with higher scores indicating greater flourishing.
Resilience: Current Experiences Scale (CES)	Up to 12 weeks	We will investigate longitudinal differences in resilience between study groups (CES score range 0-115), with higher scores indicating greater resilience.

Secondary Outcome Measures

Name	Time	Method
Psychological distress: Patient Health Questionnaire 4 (PHQ4)	Up to 12 weeks	We will investigate longitudinal differences in psychological distress between study groups (PHQ4 score range 0-12), with higher scores indicating greater distress.
Community well-being: Community Well Being Survey (CWB)	Up to 12 weeks	We will investigate longitudinal differences in community well-being between study groups (CWB range 0-10), with higher scores indicating greater community well-being.
Coping self-efficacy: Measure of Current Status - Part A (MOCS-A)	Up to 12 weeks	We will investigate longitudinal differences in coping self-efficacy between study groups (MOCS-A score range 0-52), with higher scores indicating greater self-efficacy.
Positive affect: Positive and Negative Affect Schedule - Positive Subscale (PANAS-POS)	Up to 12 weeks	We will investigate longitudinal differences in positive affect between study groups (PANAS-POS range 10-50), with higher scores indicating greater positive affect.
Physical symptoms: Condensed Memorial Symptom Assessment Scale (CMSAS)	Up to 12 weeks	We will investigate longitudinal differences in physical symptom burden between study groups (CMSAS score range 0-48, with higher scores indicating greater symptom burden.
Social isolation: Patient-Reported Outcomes Measurement Information System - Social Isolation (PROMIS-SI)	Up to 12 weeks	We will investigate longitudinal differences in social isolation between study groups (PROMIS-SI score range 4-20), with higher scores indicating greater isolation.

Trial Locations

Locations (1)

Massachusetts General Hospital; 🇺🇸 Boston, Massachusetts, United States